Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 2Phase 3 1

Status

Completed 5Withdrawn 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5

Conditions

Breast Neoplasms 5Urinary Bladder Neoplasms 1Hernia 1

Interventions

Trastuzumab 350Paclitaxel 334Cyclophosphamide 315Docetaxel 291Capecitabine 181Doxorubicin 180Letrozole 165Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 83Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 67Filgrastim 64Albumin-Bound Paclitaxel 64eribulin 55Magnetic Resonance Spectroscopy 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Alloderm × Clear all
NCT00956384 2024-12-05

AllodermRCT

University Health Network, Toronto

Phase NA Completed
198 enrolled 9 charts
Breast

Breast Neoplasms

NCT00639106 2018-10-03

Tissue Expander/Implant Reconstruction: A Single-Blinded, Randomized, Controlled Trial

Memorial Sloan Kettering Cancer Center

Phase 3 Completed
70 enrolled
Breast

Breast Neoplasms

NCT00872859 2017-05-18

The BREASTrial:Breast Reconstruction Evaluation Using Acellular Dermal Matrix as a Sling Trial

University of Utah

Phase 4 Completed
128 enrolled
Breast

Breast Neoplasms

NCT01561287 2016-05-11

A Comparison of Dermal Autograft to AlloDerm in Breast Reconstruction

University of Kentucky

Phase 4 Completed
48 enrolled
Breast

Breast Neoplasms

NCT01027637 2013-09-06

Regenerative Tissue Matrix for Breast Reconstruction

Henry Ford Health System

Phase NA Completed
33 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡